Expert Information

Currently engaged in clinical practice: Yes

Degree:

Specialty / Subspecialty:

  • Internal Medicine  -  Medical Oncology
  • Internal Medicine  -  Hematology

Area of Expertise: Multiple Myeloma, Amyloidosis, Leukemia, Lymphoma, Blood clots, Bleeding disorders

Year of Medical Training Completion: 2011

City of Practice: New York

State of Practice: New York

Previous Experience As Expert Witness: No

Type of Practice: Academic

Available to Review Cases: Yes, for either the defendant or the plaintiff

Available to Be Deposed: Yes, for either the defendant or the plaintiff

Available to Testify In Trial: Yes, for either the defendant or the plaintiff

Training and Additional Credentials

Medical School: -

Year of Completion: -

Residency: -

Year of Completion: -

Fellowship: -

Year of Completion: -

Academic / Leadership Information

Highest Academic/Leadership Position Achieved: -

Current Academic Affiliation: -

Distinguishing Achievements

Awards: -

Number of Publications on PubMed: -

Professional Organizations: -

Fee Schedule

Medical Record Review:

Review of Medical Records, Review of Additional Materials, additional office consultation

  • $250
  • $3000

Independent Medical Examination:

Independent Medical Examination with written report

  • Per Hour: -

Deposition in office:

Deposition: Discovery/Evidence

  • First two hours: -
  • For each Additional hour or any portion thereof: -
  • Retainer (due 14 days prior to scheduled disposition): -
  • Cancellation fee (less than 7 days notice): -

Trial (InState):

  • Initial day: -
  • Cancellation fee (less than 72 hours notice): -
  • For each additional day: -
  • Cancellation fee (less than 72 hours notice): -
  • Retainer (due 14 days prior to scheduled trial): -

Trial (Out of State):

  • Initial day: -
  • Cancellation fee (less than 72 hours notice): -
  • For each additional day: -
  • Cancellation fee (less than 72 hours notice): -
  • Retainer (due 14 days prior to scheduled trial): -

Case Responses

Misdiagnosis of a stage IV cancer (Case #225)

  • Medical Probability: 4 / 10
  • Medical Error Summary: A patient who has a history of breast cancer could easily have recurrence in their lifetime, even if the primary tumor was 20 years ago. The fact that a mammogram was negative Oct 2018 does not concer...
  • Causation Probability: 2 / 10
  • Causation Summary: It is very possible that the patient had no cancer at all on Nov 18 2019 and then had stage IV (metastatic) disease on November 2020. The source of metastatic disease is not even necessarily from the ...
  • Expert Summary: I am a medical oncologist, but not an expert in breast cancer.
  • Similar Summary: I am not seeing patients with breast cancer.

Diagnosis of HCC (Case #250)

  • Medical Probability: 8 / 10
  • Medical Error Summary: According to consensus guidelines and US standards of care, if HCC was confirmed back in 2014, the patient should have been offered definitive treatment. This may have included resection (if technical...
  • Causation Probability: 8 / 10
  • Causation Summary: As stated above, the delay in diagnosis of the HCC led to the tumor growing unchecked for a year. It is unknown, but likely, that the outcome for this patient would have been better had the tumor been...
  • Expert Summary: I am a medical oncologist. I have seen previous patients with HCC in my practice when I was on staff at Columbia Presbyterian Medical Center in NYC.
  • Similar Summary: yes, I have seen previous patients with HCC in my practice when I was on staff at Columbia Presbyterian Medical Center in NYC.

Failure to diagnose and treat hypodense lesion in liver consistent with metastatic disease (Case #313)

  • Medical Probability: 8 / 10
  • Medical Error Summary: This was a 80yo woman with stage 2 CRC. According to the NCCN guidelines, the standard of care in the USA is the following: • History and physical examination every 3–6 mo for 2 y, then every 6 m...
  • Causation Probability: 9 / 10
  • Causation Summary: The medical error, as stated above, was the failure to follow national guidelines for the surveillance for CRC after initial diagnosis of stage 2 disease. The oligometastatic disease identified may ha...
  • Expert Summary: I am a board certified medical oncologist and graduated from Columbia University in 2013 (10+ years experience as a medical oncologist)
  • Similar Summary: this is very common, unfortunately, in community practices.